Bortezomib (VELCADE®) in metastatic breast cancer: Pharmacodynamics, biological effects, and prediction of clinical benefits

C. H. Yang, A. M. Gonzalez-Angulo, J. M. Reuben, D. J. Booser, L. Pusztai, S. Krishnamurthy, D. Esseltine, J. Stec, K. R. Broglio, R. Islam, G. N. Hortobagyi, M. Cristofanilli*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

102 Scopus citations

Fingerprint

Dive into the research topics of 'Bortezomib (VELCADE®) in metastatic breast cancer: Pharmacodynamics, biological effects, and prediction of clinical benefits'. Together they form a unique fingerprint.

Medicine & Life Sciences